0001209191-23-020244.txt : 20230321
0001209191-23-020244.hdr.sgml : 20230321
20230321162113
ACCESSION NUMBER: 0001209191-23-020244
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20230317
FILED AS OF DATE: 20230321
DATE AS OF CHANGE: 20230321
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: WAGNER CHARLES F JR
CENTRAL INDEX KEY: 0001223348
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 000-19319
FILM NUMBER: 23749978
MAIL ADDRESS:
STREET 1: C/O MILLIPORE CORP
CITY: BILLERICA
STATE: MA
ZIP: 01820
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: VERTEX PHARMACEUTICALS INC / MA
CENTRAL INDEX KEY: 0000875320
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 043039129
STATE OF INCORPORATION: MA
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 50 NORTHERN AVENUE
CITY: BOSTON
STATE: MA
ZIP: 02210
BUSINESS PHONE: 6173416393
MAIL ADDRESS:
STREET 1: 50 NORTHERN AVENUE
CITY: BOSTON
STATE: MA
ZIP: 02210
4
1
doc4.xml
FORM 4 SUBMISSION
X0407
4
2023-03-17
0
0000875320
VERTEX PHARMACEUTICALS INC / MA
VRTX
0001223348
WAGNER CHARLES F JR
C/O VERTEX PHARMACEUTICALS INCORPORATED
50 NORTHERN AVENUE
BOSTON
MA
02210
0
1
0
0
EVP & Chief Financial Officer
1
Common Stock
2023-03-17
4
S
0
360
294.52
D
53019
D
Common Stock
2023-03-17
4
S
0
784
295.43
D
52235
D
Common Stock
2023-03-17
4
S
0
240
296.30
D
51995
D
Common Stock
2023-03-17
4
S
0
360
298.09
D
51635
D
Common Stock
2023-03-17
4
S
0
240
299.58
D
51395
D
Common Stock
2023-03-17
4
S
0
16
301.13
D
51379
D
Transaction made pursuant to Mr. Wagner's company approved trading plan under Rule 10b5-1, which was adopted on 08/08/2022.
Mr. Wagner undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares sold at each separate price.
Open market sales reported on this line occurred at a weighted average price of $294.52 (range $293.98 to $294.81).
Open market sales reported on this line occurred at a weighted average price of $295.43 (range $295.09 to $295.97).
Open market sales reported on this line occurred at a weighted average price of $296.30 (range $296.14 to $296.45).
Open market sales reported on this line occurred at a weighted average price of $298.09 (range $297.65 to $298.48).
Open market sales reported on this line occurred at a weighted average price of $299.58 (range $299.09 to $300.06).
/s/ Christiana Stevenson, Attorney-in-Fact
2023-03-21